Holen Sie sich die Stockscreener-App
228.65
0.67%
1.53
Alnylam Pharmaceuticals Inc Aktie (ALNY) Neueste Nachrichten
NASDAQ: ALNY Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Investors to Contact the Firm - The AI Journal
ALNY Maintains Equal-Weight by Wells Fargo -- Price Target Lowered to $256 - GuruFocus
Alnylam Pharmaceuticals (NASDAQ:ALNY) Given New $256.00 Price Target at Wells Fargo & Company - MarketBeat
Alnylam Pharmaceuticals (ALNY) Cuts Guidance As Undervalued Narrative Faces A Tougher Test - simplywall.st
Stifel Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $318 - Moomoo
Securities Fraud Investigation Into Alnylam - GlobeNewswire
Securities Fraud Investigation Into Alnylam Pharmaceuticals, Inc. (ALNY) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - WBOC TV
Is Alnylam’s Mixed 2026 Guidance Reset Altering The Investment Case For Alny (ALNY)? - simplywall.st
Handelsbanken Fonder AB Sells 29,207 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Drugs that missed the mark in pharma’s last earnings round - Pharma Voice
Alnylam Pharmaceuticals (ALNY) Short Interest & Short Float | Updated Aug 2026 $ALNY - MarketBeat
$1000 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth This Much Today - Benzinga
Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Exploring a 71% Potential Upside Amid Strong Revenue Growth - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
PensionDanmark Pensionsforsikringsaktieselskab Sells 12,119 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Pacer Advisors Inc. Sells 5,110 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Assenagon Asset Management S.A. Has $46.87 Million Holdings in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam Pharmaceuticals, Inc. (ALNY) Stock forecasts - Yahoo Finance UK
Research Analysts Offer Predictions for ALNY Q3 Earnings - MarketBeat
ALNYLAM PHARMACEUTICALS INC (1ALNY.MI) stock price, news, quote and history - Yahoo Finance Singapore
Empowered Funds LLC Lowers Stock Position in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam Pharmaceuticals (ALNY) On Lowered TTR Guidance And What It Means For Valuation - simplywall.st
Implied Volatility Surging for Alnylam Pharmaceuticals Stock Options - Yahoo Finance
ALNYLAM INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Truist Financial Issues Pessimistic Forecast for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price - MarketBeat
Securities Fraud Investigation into Alnylam - GlobeNewswire
Alnylam (ALNY) Turns Profitable as Revenue Mix Shifts: What Changes in Its Investment Story? - simplywall.st
Quantinno Capital Management LP Purchases 8,258 Shares of Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
ALNY Investors Have Opportunity to Join Alnylam Pharmaceuticals, Inc. Fraud Investigation with SBS Law - Business Wire
Barclays Lowers Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $450.00 - MarketBeat
Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: 87.96% Potential Upside Beckons Investors - DirectorsTalk Interviews
ALNYLAM PHARMACEUTICALS INC : RAYMOND JAMES CUTS TARGET PRICE TO $420 FROM $468 - webull.com
Alnylam Pharmaceuticals (NASDAQ:ALNY) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Alnylam Pharmaceuticals (NASDAQ:ALNY): Affordable Growth at a Reasonable Valuation - ChartMill
Alnylam (ALNY) Stock Stalls As TTR Sales Top $1b And Guidance Tightens - simplywall.st
Alnylam Pharmaceuticals Is Maintained at Equal-Weight by Wells Fargo - Moomoo
Wells Fargo & Company Has Lowered Expectations for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price - MarketBeat
Alnylam Pharmaceuticals, Inc. (ALNY) Stock Forecasts - finance.yahoo.com
Alnylam Pharmaceuticals Inc (ALNY) (Q2 2026) Earnings Call Highl - GuruFocus
Alnylam: Q2 Earnings Snapshot - 10TV
Alnylam Pharmaceuticals (NASDAQ:ALNY) Hits New 52-Week LowShould You Sell? - MarketBeat
Alnylam (ALNY) Is Up 6.3% After Showcasing New Alzheimer’s RNAi Data And $1B-Plus Quarterly Revenue - Yahoo Finance
Unlocking Q2 Potential of Alnylam (ALNY): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
Why Alnylam’s Best Quarter Ever Didn’t Come With a Richer Valuation - Yahoo Finance
Did Alnylam’s Alzheimer’s Pipeline Advances Just Shift Alnylam Pharmaceuticals' (ALNY) Investment Narrative? - simplywall.st
Alnylam Rises as Investors Weigh Pipeline Momentum, Earnings Setup, and ATTR-CM Positioning - Quiver Quantitative
Alnylam Pharmaceuticals Inc (ALNY) Institutional Confidence - TradingKey
Alnylam Pharmaceuticals Inc (ALNY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alnylam Pharmaceuticals (ALNY) Could Be 38% Undervalued After Mivelsiran Trial Progress - simplywall.st
BR:A1LN34 Stock Latest News - TipRanks
Alnylam Pharmaceuticals, Inc. (ALNY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Alnylam Pharmaceuticals Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Alnylam Pharmaceuticals, Inc. (ALNY) stock price, news, quote and history - Yahoo Finance Australia
ALNY Stock Price TodayAlnylam Pharmaceuticals Inc News, Charts, Retail Sentiment - Stocktwits
Alnylam stock trades steady as RNAi pipeline advances and cash position supports development - Ad-hoc-news.de
Alnylam Pharmaceuticals (ALNY) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
ALNY Maintains Overweight by JP Morgan -- Price Target Lowered t - GuruFocus
Alnylam Pharmaceuticals Price Target Cut to $400.00/Share From $420.00 by JP Morgan - Moomoo
ALNY|Alnylam Pharmaceuticals Inc|Price:269.400|Chg%:+0.660 - TradingKey
US2043QAC1 Bond Profile — Key Metrics - TradingView
Biomarker Collaboration and Licensing Deals Report 2016-2026Featuring Quanterix, Caris Life Sciences, Alnylam Pharmaceuticals, Guardant Health, Eurofins Scientific and More - Yahoo Finance
Alnylam Pharmaceuticals (ALNY) Q2 2024 earnings summary - Quartr
Alnylam Stock And 2 US Health Care Names With Earnings In Focus - simplywall.st
2.05%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):